NewcelX Ltd. (NCEL)
NASDAQ: NCEL · Real-Time Price · USD
2.970
+0.050 (1.71%)
At close: Sep 29, 2026, 4:00 PM EDT
2.900
-0.070 (-2.36%)
After-hours: Sep 29, 2026, 4:10 PM EDT
NewcelX Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
12
Market Cap
17.16M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Palatin Technologies | 12.88M |
| Lipocine | 1.57M |
| Allarity Therapeutics | 345.00K |
| Kiora Pharmaceuticals | 20.00K |
| BioCardia | 3.00K |
NCEL News
- 1 day ago - NewCelX Management to Attend Breakthrough T1D Congress in Philadelphia, Advancing Its Mission to Develop a Cure for Type 1 Diabetes - GlobeNewsWire
- 5 weeks ago - NewcelX registers to sell 694K common shares for holders - TheFly
- 2 months ago - NewcelX announces pricing of $1.4M equity financing - TheFly
- 2 months ago - NewcelX Announces Pricing of $1.4 Million Equity Financing at 20% Premium Pricing - GlobeNewsWire
- 2 months ago - NewcelX announces Brazil patent for cell selection, enrichment technology - TheFly
- 2 months ago - NewcelX initiated with a Buy at Laidlaw - TheFly
- 2 months ago - NewcelX Appoints World-Renowned Diabetes Cure-Focused Pioneer, Dr. Camillo Ricordi, to Scientific Advisory Board - GlobeNewsWire
- 3 months ago - NewcelX completes Type B Pre-IND meeting with FDA for NCEL-101 - TheFly